Mr. Jim Breslin:

We were dealing with the same issue, which is that we were looking at a surge, but we were using different remedies. One was to try to flatten the curve and stop the surge, but we knew that even if we were successful, there was a lag in the incubation period. Meanwhile, we were trying to put the capacity in place for the surge. The fact that the first strategy worked meant we did not need as much in the second, but they were both valuable strategies.